Consultants Forum Advertise
Subscribe

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development

Becton, Dickinson and Company Expands Columbus, Nebraska, Operations

02/15/2026
American medical technology and device manufacturer Becton, Dickinson and Company plans to expand its operations in Columbus, Nebraska. The $110 million project is expected to create approximately 120 jobs.

The investment at the company’s existing site will support production of Neopak Glass Prefillable Syringes and increase cannula manufacturing capabilities.

"As demand for biologics and GLP-1s accelerates, BD is strengthening its American manufacturing footprint to support U.S.-based drug delivery innovation and supply chain resiliency," said Patrick Jeukenne, worldwide president of BD Pharmaceutical Systems. "This investment in Nebraska, advances our long-term growth strategy and reflects our commitment to partnering with biopharmaceutical innovators as they bring advanced therapies to patients who require next-generation drug delivery solutions."

Becton, Dickinson and Company (BD) develops, produces, and sells a broad portfolio of diagnostic instruments, medical supplies, and laboratory equipment. The company’s products include needles and syringes, infusion systems, diagnostic systems, and devices for medication management, serving hospitals, clinics, research labs, and public health organizations.

"This is another perfect example of a company with global reach producing high value, cutting edge products at its plant right here in Nebraska,” noted Nebraska Governor Jim Pillen. “We can compete with anyone in the world and we are the best at what we do because of our people. The announcement of this expansion for BD is exciting news."

Podcast

Apple Podcasts Spotify

Magazine

Past Issues
Area Development Magazine Q4 2025
Q4 2025

Receive quarterly issues of Area Development Magazine at no charge for qualified executives and consultants to industry.

Exclusive Research